Podcasts about daraprim

Why You Should Listen:  In this episode, you will learn the role of Toxoplasmosis in chronic illness and approaches for addressing it. About My Guest: My guest for this episode is Dr. Eboni Cornish.   Eboni Cornish, MD, a highly regarded  physician, provides integrative medicine services to a diverse global patient community.  Currently serving as the Functional Medicine Director of the Amen Clinic East Coast Division, she specializes in autoimmune diseases, Lyme disease, environmental toxicity, gut imbalances, neurology and various other chronic conditions.  Employing a holistic approach, Dr. Cornish identifies the root causes of health issues within the body's biological systems, offering comprehensive treatment to adults and children. Her treatment philosophy is integrative and evidence-based.  Within Amen Clinics, Dr. Cornish has been instrumental in developing the Neuroinflammatory Intensive program—a two-week inpatient initiative addressing neurological complications arising from chronic infectious diseases, Lyme disease, mold illness, and other chronic inflammatory conditions including SPECT imaging.  Dr. Cornish's educational journey includes earning honors at Brown University for her undergraduate studies and obtaining her medical degree from Brown University Medical School. She further refined her skills through a family medicine residency at Georgetown University.  As a Howard Hughes Medical Fellow, Dr. Cornish conducted translational research at the National Human Genome Research Institute NIH, working under Francis Collins, MD, PhD.   She currently serves as the Treasurer of the board for the International Lyme and Associated Diseases Society and a fellow of the Institute of Functional Medicine.  Key Takeaways: What symptoms present in those with Toxoplasmosis? What conditions might Toxoplasma contribute to? How prevalent is Toxoplasma? How do people acquire Toxoplasma? What role do cats play in the transmission of Toxoplasma? Can Toxoplasma be transmitted by ticks? What are the best methods for testing for Toxoplasma? What is observed in these patients using SPECT scans? Does mold exposure potentially make Toxoplasma worse? Can Toxoplasma be a trigger for mast cells? How important is immune modulation as part of a treatment protocol? What pharmaceutical and natural options have been most helpful for treating those with Toxoplasma? Is there a place for homeopathy or frequency medicine? What is the connection between Toxoplasma and calcification? How important is limbic system retraining in these patients? Connect With My Guest:  http://AmenClinics.com Interview Date: February 23, 2024 Transcript: To review a transcript of this show, visit https://BetterHealthGuy.com/Episode197. Additional Information: To learn more, visit https://BetterHealthGuy.com. Disclaimer:  The content of this show is for informational purposes only and is not intended to diagnose, treat, or cure any illness or medical condition. Nothing in today's discussion is meant to serve as medical advice or as information to facilitate self-treatment. As always, please discuss any potential health-related decisions with your own personal medical authority. 

La industria farmacéutica desempeña un papel crucial en la sociedad al proporcionar medicamentos y tratamientos que mejoran y salvan vidas. Sin embargo, como en cualquier industria, también ha sido escenario de casos de fraude, estafas y mala praxis. Estos incidentes no solo erosionan la confianza del público en la industria, sino que también plantean cuestionamientos éticos sobre la priorización de las ganancias por encima de la salud y el bienestar de los pacientes. En este artículo, exploraremos algunos ejemplos notorios de fraudes, estafas y mala praxis en la industria farmacéutica, así como las implicaciones y las medidas tomadas para abordar estos problemas. Casos Emblemáticos de Fraude y Estafas Caso Turing Pharmaceuticals y el aumento de precios de Daraprim: En 2015, Turing Pharmaceuticals, dirigida por Martin Shkreli, adquirió los derechos del medicamento Daraprim, utilizado en el tratamiento de infecciones parasitarias. La compañía aumentó drásticamente el precio del medicamento en un 5,000%, lo que generó indignación pública y puso de relieve las prácticas de fijación de precios abusivas en la industria. Caso Insys Therapeutics y el opioidi OxyContin: Insys Therapeutics promovió de manera agresiva su fentanilo de acción rápida, Subsys, para el tratamiento del dolor, incluso cuando no estaba indicado. La compañía se enfrentó a acusaciones de sobornar a médicos para recetar el medicamento y participar en tácticas de marketing engañosas, lo que contribuyó a la crisis de opioides en Estados Unidos. Caso GlaxoSmithKline y el escándalo del Paxil: La compañía farmacéutica GlaxoSmithKline fue acusada de ocultar datos sobre la seguridad y eficacia del antidepresivo Paxil en pacientes jóvenes. También se reveló que GSK había sobornado a médicos y manipulado la información en beneficio propio. Casos de Mala Praxis y Fallos en la Investigación Retiro de medicamentos después de la aprobación: En ocasiones, medicamentos que han sido aprobados por las agencias reguladoras se retiran del mercado debido a problemas de seguridad que no se identificaron durante los ensayos clínicos. Ejemplos notables incluyen el retiro del medicamento Vioxx de Merck por aumentar el riesgo de ataques cardíacos y accidentes cerebrovasculares. Estudios clínicos sesgados: Se han documentado casos en los que los resultados de estudios clínicos son manipulados o sesgados para favorecer los intereses de la empresa farmacéutica patrocinadora. Esto puede llevar a la aprobación de medicamentos que en realidad no son tan seguros o efectivos como se afirma. Implicaciones y Medidas Correctivas Los casos de fraude, estafas y mala praxis en la industria farmacéutica tienen implicaciones graves para la salud pública y la confianza en el sistema de atención médica. Para abordar estos problemas, se han tomado y se siguen tomando diversas medidas: Mayor transparencia: Las agencias reguladoras y las empresas farmacéuticas están bajo presión para aumentar la transparencia en la divulgación de datos de ensayos clínicos y en la presentación de informes sobre la seguridad y eficacia de los medicamentos. Regulaciones más estrictas: Se están implementando regulaciones más estrictas para prevenir la fijación de precios abusivos y para garantizar que los medicamentos se receten de manera adecuada y segura. Control de conflictos de interés: Se están adoptando medidas para controlar los conflictos de interés en la relación entre médicos y la industria farmacéutica, como la divulgación pública de las relaciones financieras. Mayor supervisión y sanciones: Las empresas y personas involucradas en prácticas fraudulentas o de mala praxis están siendo investigadas y, en algunos casos, enfrentan sanciones legales y multas significativas. Conclusión Si bien la mayoría de las empresas farmacéuticas están comprometidas con el desarrollo y la comercialización de tratamientos que mejoran la salud humana, los casos de fraude, estafas y mala praxis han sacudido la confianza del público en la industria. Es esencial continuar trabajando en la implementación de regulaciones más estrictas, la promoción de la transparencia y la ética, y la vigilancia constante para garantizar que los pacientes reciban medicamentos seguros y efectivos sin que se comprometa su bienestar en aras de las ganancias. ---------------------------------------------------------------------------------------------------------------- Antena Historia te regala 30 días PREMIUM, para que lo disfrutes https://www.ivoox.com/premium?affiliate-code=b4688a50868967db9ca413741a54cea5 ---------------------------------------------------------------------------------------- Produce Antonio Cruz Edita ANTENA HISTORIA Antena Historia (podcast) forma parte del sello iVoox Originals ---------------------------------------------------------------------------------------- web……….https://antenahistoria.com/ correo.....info@antenahistoria.com Facebook…..Antena Historia Podcast | Facebook Twitter…...https://twitter.com/AntenaHistoria Telegram…...https://t.me/foroantenahistoria DONACIONES PAYPAL...... https://paypal.me/ancrume ---------------------------------------------------------------------------------------- ¿QUIERES ANUNCIARTE en ANTENA HISTORIA?, menciones, cuñas publicitarias, programas personalizados, etc. Dirígete a Antena Historia - AdVoices Escucha el episodio completo en la app de iVoox, o descubre todo el catálogo de iVoox Originals

La industria farmacéutica desempeña un papel crucial en la sociedad al proporcionar medicamentos y tratamientos que mejoran y salvan vidas. Sin embargo, como en cualquier industria, también ha sido escenario de casos de fraude, estafas y mala praxis. Estos incidentes no solo erosionan la confianza del público en la industria, sino que también plantean cuestionamientos éticos sobre la priorización de las ganancias por encima de la salud y el bienestar de los pacientes. En este artículo, exploraremos algunos ejemplos notorios de fraudes, estafas y mala praxis en la industria farmacéutica, así como las implicaciones y las medidas tomadas para abordar estos problemas. Casos Emblemáticos de Fraude y Estafas Caso Turing Pharmaceuticals y el aumento de precios de Daraprim: En 2015, Turing Pharmaceuticals, dirigida por Martin Shkreli, adquirió los derechos del medicamento Daraprim, utilizado en el tratamiento de infecciones parasitarias. La compañía aumentó drásticamente el precio del medicamento en un 5,000%, lo que generó indignación pública y puso de relieve las prácticas de fijación de precios abusivas en la industria. Caso Insys Therapeutics y el opioidi OxyContin: Insys Therapeutics promovió de manera agresiva su fentanilo de acción rápida, Subsys, para el tratamiento del dolor, incluso cuando no estaba indicado. La compañía se enfrentó a acusaciones de sobornar a médicos para recetar el medicamento y participar en tácticas de marketing engañosas, lo que contribuyó a la crisis de opioides en Estados Unidos. Caso GlaxoSmithKline y el escándalo del Paxil: La compañía farmacéutica GlaxoSmithKline fue acusada de ocultar datos sobre la seguridad y eficacia del antidepresivo Paxil en pacientes jóvenes. También se reveló que GSK había sobornado a médicos y manipulado la información en beneficio propio. Casos de Mala Praxis y Fallos en la Investigación Retiro de medicamentos después de la aprobación: En ocasiones, medicamentos que han sido aprobados por las agencias reguladoras se retiran del mercado debido a problemas de seguridad que no se identificaron durante los ensayos clínicos. Ejemplos notables incluyen el retiro del medicamento Vioxx de Merck por aumentar el riesgo de ataques cardíacos y accidentes cerebrovasculares. Estudios clínicos sesgados: Se han documentado casos en los que los resultados de estudios clínicos son manipulados o sesgados para favorecer los intereses de la empresa farmacéutica patrocinadora. Esto puede llevar a la aprobación de medicamentos que en realidad no son tan seguros o efectivos como se afirma. Implicaciones y Medidas Correctivas Los casos de fraude, estafas y mala praxis en la industria farmacéutica tienen implicaciones graves para la salud pública y la confianza en el sistema de atención médica. Para abordar estos problemas, se han tomado y se siguen tomando diversas medidas: Mayor transparencia: Las agencias reguladoras y las empresas farmacéuticas están bajo presión para aumentar la transparencia en la divulgación de datos de ensayos clínicos y en la presentación de informes sobre la seguridad y eficacia de los medicamentos. Regulaciones más estrictas: Se están implementando regulaciones más estrictas para prevenir la fijación de precios abusivos y para garantizar que los medicamentos se receten de manera adecuada y segura. Control de conflictos de interés: Se están adoptando medidas para controlar los conflictos de interés en la relación entre médicos y la industria farmacéutica, como la divulgación pública de las relaciones financieras. Mayor supervisión y sanciones: Las empresas y personas involucradas en prácticas fraudulentas o de mala praxis están siendo investigadas y, en algunos casos, enfrentan sanciones legales y multas significativas. Conclusión Si bien la mayoría de las empresas farmacéuticas están comprometidas con el desarrollo y la comercialización de tratamientos que mejoran la salud humana, los casos de fraude, estafas y mala praxis han sacudido la confianza del público en la industria. Es esencial continuar trabajando en la implementación de regulaciones más estrictas, la promoción de la transparencia y la ética, y la vigilancia constante para garantizar que los pacientes reciban medicamentos seguros y efectivos sin que se comprometa su bienestar en aras de las ganancias. ---------------------------------------------------------------------------------------------------------------- Antena Historia te regala 30 días PREMIUM, para que lo disfrutes https://www.ivoox.com/premium?affiliate-code=b4688a50868967db9ca413741a54cea5 ---------------------------------------------------------------------------------------- Produce Antonio Cruz Edita ANTENA HISTORIA Antena Historia (podcast) forma parte del sello iVoox Originals ---------------------------------------------------------------------------------------- web……….https://antenahistoria.com/ correo.....info@antenahistoria.com Facebook…..Antena Historia Podcast | Facebook Twitter…...https://twitter.com/AntenaHistoria Telegram…...https://t.me/foroantenahistoria DONACIONES PAYPAL...... https://paypal.me/ancrume ---------------------------------------------------------------------------------------- ¿QUIERES ANUNCIARTE en ANTENA HISTORIA?, menciones, cuñas publicitarias, programas personalizados, etc. Dirígete a Antena Historia - AdVoices Escucha el episodio completo en la app de iVoox, o descubre todo el catálogo de iVoox Originals

Michael Malice (“YOUR WELCOME”) welcomes biotech founder, Martin Shkreli, onto the show to talk about the Daraprim controversy, how hard it is to tell your side of the story when American media has already painted you as the enemy, and the one federal agency Martin surprisingly thinks is good at what they do. Martin and Michael also discuss his time in prison, and the one joke that led to his bail being revoked. linktr.ee/martinshkreli instagram.com/martinshkreli15/ youtube.com/channel/UCjYKsjt-7EDU78KEcVbhYnQ Order THE WHITE PILL: http://whitepillbook.com/ Order THE ANARCHIST HANDBOOK: https://www.amzn.com/B095DVF8FJ Order THE NEW RIGHT: https://amzn.to/2IFFCCu Order DEAR READER: https://t.co/vZfTVkK6qf?amp=1 https://twitter.com/michaelmalice https://instagram.com/michaelmalice https://malice.locals.com https://youtube.com/michaelmaliceofficial Intro song: "Out of Reach" by Legendary House Cats https://thelegendaryhousecats.bandcamp.com/ The newest episode of "YOUR WELCOME" releases on iTunes and YouTube every Thursday! Please subscribe and leave a review. This week's sponsors: 4Patriots – Survival Food Kits: 4Patriots.com, promo code: MALICE (10% off) Fum - The Natural Alternative: tryfum.com, promo code: MALICE (10% off) Patriot Gold Group – No Fee IRA: Call 888-505-9845 or visit malicegold.com (Free investor guide) PlutoTV – Streaming TV: Pluto.tv Progressive – Name Your Price Tool: progressive.com

My First Million Key Takeaways  Martin Shkreli worked for Jim Cramer's hedge fund when he was in high school Martin became a millionaire at the age of 29 when he took his pharma company public “PubMed is the government database of all scholastic biomedical literature – so 36 million papers. If you sit there long enough and you have the passion, you can become a billionaire.” – Martin Shkreli It is not a crime to choose the price of your product He was bothered by the politicians trying to take the right away from entrepreneurs to set the price of their products, what he calls “regulation by embarrassment” If the regulators can tell Martin Shkreli what the price of his product should be, what is stopping them from setting the price of the iPhone? How much should a drug cost if it prevents the need for getting a $1 million surgery?After raising the price of the drug, there were zero patients that were unable to get the drug He hoped his casualness would encourage them to do some research and find out that no one (other than the insurance companies) were affected by the price increase Modern CEOs are not allowed to have a real personality: no one in the corporate world is allowed to have an opinion because it might be held against them or their companyMagic happens when you provide capital to great people with great assetsHealthcare is more expensive than we'd like mostly because of the artificially constrained supply of healthcare professionals, according to Martin Shkreli  Read the full notes @ podcastnotes.orgEpisode 445: Shaan Puri (@ShaanVP) and Sam Parr (@TheSamParr) talk with Martin Shkreli (@marty_catboy), aka "the most hated man in America", about how he got started in pharma, his logic behind raising the price of Daraprim, why he spent time in prison, and what business he's starting now. Vote for MFM to win a Webby: mfmpod.com/webby Click here to sign up for our event in Austin, TX on Saturday April 29th: mfmpod.com/atx Want to see more MFM? Subscribe to the MFM YouTube channel here. Check Out Sam's Stuff: * Hampton * Ideation Bootcamp * Copy That Check Out Shaan's Stuff: * Power Writing Course * Daily Newsletter ----- Links: *Dr. Gupta AI *@martinshkreli15 (Instagram) * Do you love MFM and want to see Sam and Shaan's smiling faces? Subscribe to our Youtube channel. ------ Show Notes: (00:30) - Intro to Martin Shkreli (02:10) - When Martin worked with Jim Cramer (23:00) - How he turned $2M into $1B in pharma (35:40) - Why did you jack up the price of the drugs? (54:20) - What do you do with your money? (01:00:33) - The Fun Strikes Back Movement (01:08:30) - Introducing Martin's New Company: Dr. Gupta AI (01:33:50) - Who are your heroes? ------ Past guests on My First Million include Rob Dyrdek, Hasan Minhaj, Balaji Srinivasan, Jake Paul, Dr. Andrew Huberman, Gary Vee, Lance Armstrong, Sophia Amoruso, Ariel Helwani, Ramit Sethi, Stanley Druckenmiller, Peter Diamandis, Dharmesh Shah, Brian Halligan, Marc Lore, Jason Calacanis, Andrew Wilkinson, Julian Shapiro, Kat Cole, Codie Sanchez, Nader Al-Naji, Steph Smith, Trung Phan, Nick Huber, Anthony Pompliano, Ben Askren, Ramon Van Meer, Brianne Kimmel, Andrew Gazdecki, Scott Belsky, Moiz Ali, Dan Held, Elaine Zelby, Michael Saylor, Ryan Begelman, Jack Butcher, Reed Duchscher, Tai Lopez, Harley Finkelstein, Alexa von Tobel, Noah Kagan, Nick Bare, Greg Isenberg, James Altucher, Randy Hetrick and more. ----- Additional episodes you might enjoy: • #224 Rob Dyrdek - How Tracking Every Second of His Life Took Rob Drydek from 0 to $405M in Exits • #209 Gary Vaynerchuk - Why NFTS Are the Future • #178 Balaji Srinivasan - Balaji on How to Fix the Media, Cloud Cities & Crypto * #169 - How One Man Started 5, Billion Dollar Companies, Dan Gilbert's Empire, & Talking With Warren Buffett • ​​​​#218 - Why You Should Take a Think Week Like Bill Gates • Dave Portnoy vs The World, Extreme Body Monitoring, The Future of Apparel Retail, "How Much is Anthony Pompliano Worth?", and More • How Mr Beast Got 100M Views in Less Than 4 Days, The $25M Chrome Extension, and More

My First Million Key Takeaways  Martin Shkreli worked for Jim Cramer's hedge fund when he was in high school Martin became a millionaire at the age of 29 when he took his pharma company public “PubMed is the government database of all scholastic biomedical literature – so 36 million papers. If you sit there long enough and you have the passion, you can become a billionaire.” – Martin Shkreli It is not a crime to choose the price of your product He was bothered by the politicians trying to take the right away from entrepreneurs to set the price of their products, what he calls “regulation by embarrassment” If the regulators can tell Martin Shkreli what the price of his product should be, what is stopping them from setting the price of the iPhone? How much should a drug cost if it prevents the need for getting a $1 million surgery?After raising the price of the drug, there were zero patients that were unable to get the drug He hoped his casualness would encourage them to do some research and find out that no one (other than the insurance companies) were affected by the price increase Modern CEOs are not allowed to have a real personality: no one in the corporate world is allowed to have an opinion because it might be held against them or their companyMagic happens when you provide capital to great people with great assetsHealthcare is more expensive than we'd like mostly because of the artificially constrained supply of healthcare professionals, according to Martin Shkreli  Read the full notes @ podcastnotes.orgEpisode 445: Shaan Puri (@ShaanVP) and Sam Parr (@TheSamParr) talk with Martin Shkreli (@marty_catboy), aka "the most hated man in America", about how he got started in pharma, his logic behind raising the price of Daraprim, why he spent time in prison, and what business he's starting now. Vote for MFM to win a Webby: mfmpod.com/webby Click here to sign up for our event in Austin, TX on Saturday April 29th: mfmpod.com/atx Want to see more MFM? Subscribe to the MFM YouTube channel here. Check Out Sam's Stuff: * Hampton * Ideation Bootcamp * Copy That Check Out Shaan's Stuff: * Power Writing Course * Daily Newsletter ----- Links: *Dr. Gupta AI *@martinshkreli15 (Instagram) * Do you love MFM and want to see Sam and Shaan's smiling faces? Subscribe to our Youtube channel. ------ Show Notes: (00:30) - Intro to Martin Shkreli (02:10) - When Martin worked with Jim Cramer (23:00) - How he turned $2M into $1B in pharma (35:40) - Why did you jack up the price of the drugs? (54:20) - What do you do with your money? (01:00:33) - The Fun Strikes Back Movement (01:08:30) - Introducing Martin's New Company: Dr. Gupta AI (01:33:50) - Who are your heroes? ------ Past guests on My First Million include Rob Dyrdek, Hasan Minhaj, Balaji Srinivasan, Jake Paul, Dr. Andrew Huberman, Gary Vee, Lance Armstrong, Sophia Amoruso, Ariel Helwani, Ramit Sethi, Stanley Druckenmiller, Peter Diamandis, Dharmesh Shah, Brian Halligan, Marc Lore, Jason Calacanis, Andrew Wilkinson, Julian Shapiro, Kat Cole, Codie Sanchez, Nader Al-Naji, Steph Smith, Trung Phan, Nick Huber, Anthony Pompliano, Ben Askren, Ramon Van Meer, Brianne Kimmel, Andrew Gazdecki, Scott Belsky, Moiz Ali, Dan Held, Elaine Zelby, Michael Saylor, Ryan Begelman, Jack Butcher, Reed Duchscher, Tai Lopez, Harley Finkelstein, Alexa von Tobel, Noah Kagan, Nick Bare, Greg Isenberg, James Altucher, Randy Hetrick and more. ----- Additional episodes you might enjoy: • #224 Rob Dyrdek - How Tracking Every Second of His Life Took Rob Drydek from 0 to $405M in Exits • #209 Gary Vaynerchuk - Why NFTS Are the Future • #178 Balaji Srinivasan - Balaji on How to Fix the Media, Cloud Cities & Crypto * #169 - How One Man Started 5, Billion Dollar Companies, Dan Gilbert's Empire, & Talking With Warren Buffett • ​​​​#218 - Why You Should Take a Think Week Like Bill Gates • Dave Portnoy vs The World, Extreme Body Monitoring, The Future of Apparel Retail, "How Much is Anthony Pompliano Worth?", and More • How Mr Beast Got 100M Views in Less Than 4 Days, The $25M Chrome Extension, and More

My First Million Key Takeaways  Martin Shkreli worked for Jim Cramer's hedge fund when he was in high school Martin became a millionaire at the age of 29 when he took his pharma company public “PubMed is the government database of all scholastic biomedical literature – so 36 million papers. If you sit there long enough and you have the passion, you can become a billionaire.” – Martin Shkreli It is not a crime to choose the price of your product He was bothered by the politicians trying to take the right away from entrepreneurs to set the price of their products, what he calls “regulation by embarrassment” If the regulators can tell Martin Shkreli what the price of his product should be, what is stopping them from setting the price of the iPhone? How much should a drug cost if it prevents the need for getting a $1 million surgery?After raising the price of the drug, there were zero patients that were unable to get the drug He hoped his casualness would encourage them to do some research and find out that no one (other than the insurance companies) were affected by the price increase Modern CEOs are not allowed to have a real personality: no one in the corporate world is allowed to have an opinion because it might be held against them or their companyMagic happens when you provide capital to great people with great assetsHealthcare is more expensive than we'd like mostly because of the artificially constrained supply of healthcare professionals, according to Martin Shkreli  Read the full notes @ podcastnotes.orgEpisode 445: Shaan Puri (@ShaanVP) and Sam Parr (@TheSamParr) talk with Martin Shkreli (@marty_catboy), aka "the most hated man in America", about how he got started in pharma, his logic behind raising the price of Daraprim, why he spent time in prison, and what business he's starting now. Vote for MFM to win a Webby: mfmpod.com/webby Click here to sign up for our event in Austin, TX on Saturday April 29th: mfmpod.com/atx Want to see more MFM? Subscribe to the MFM YouTube channel here. Check Out Sam's Stuff: * Hampton * Ideation Bootcamp * Copy That Check Out Shaan's Stuff: * Power Writing Course * Daily Newsletter ----- Links: *Dr. Gupta AI *@martinshkreli15 (Instagram) * Do you love MFM and want to see Sam and Shaan's smiling faces? Subscribe to our Youtube channel. ------ Show Notes: (00:30) - Intro to Martin Shkreli (02:10) - When Martin worked with Jim Cramer (23:00) - How he turned $2M into $1B in pharma (35:40) - Why did you jack up the price of the drugs? (54:20) - What do you do with your money? (01:00:33) - The Fun Strikes Back Movement (01:08:30) - Introducing Martin's New Company: Dr. Gupta AI (01:33:50) - Who are your heroes? ------ Past guests on My First Million include Rob Dyrdek, Hasan Minhaj, Balaji Srinivasan, Jake Paul, Dr. Andrew Huberman, Gary Vee, Lance Armstrong, Sophia Amoruso, Ariel Helwani, Ramit Sethi, Stanley Druckenmiller, Peter Diamandis, Dharmesh Shah, Brian Halligan, Marc Lore, Jason Calacanis, Andrew Wilkinson, Julian Shapiro, Kat Cole, Codie Sanchez, Nader Al-Naji, Steph Smith, Trung Phan, Nick Huber, Anthony Pompliano, Ben Askren, Ramon Van Meer, Brianne Kimmel, Andrew Gazdecki, Scott Belsky, Moiz Ali, Dan Held, Elaine Zelby, Michael Saylor, Ryan Begelman, Jack Butcher, Reed Duchscher, Tai Lopez, Harley Finkelstein, Alexa von Tobel, Noah Kagan, Nick Bare, Greg Isenberg, James Altucher, Randy Hetrick and more. ----- Additional episodes you might enjoy: • #224 Rob Dyrdek - How Tracking Every Second of His Life Took Rob Drydek from 0 to $405M in Exits • #209 Gary Vaynerchuk - Why NFTS Are the Future • #178 Balaji Srinivasan - Balaji on How to Fix the Media, Cloud Cities & Crypto * #169 - How One Man Started 5, Billion Dollar Companies, Dan Gilbert's Empire, & Talking With Warren Buffett • ​​​​#218 - Why You Should Take a Think Week Like Bill Gates • Dave Portnoy vs The World, Extreme Body Monitoring, The Future of Apparel Retail, "How Much is Anthony Pompliano Worth?", and More • How Mr Beast Got 100M Views in Less Than 4 Days, The $25M Chrome Extension, and More

Martin Shkreli is an American Investor, Pharmaceutical Executive and Hedge Fund Manager who became the most hated man in America in 2015 when he obtained the drug Daraprim and increased its price from $13.50 a pill, to $750 overnight. 0:00 Intro 1:56 The Big Short 8:04 How to price a drug 20:01 Should we price drugs like iPhones 25:36 Pharma's dirty secret with R&D spend 34:12 Why are we not discovering more drugs? Eroom's Law 43:59 Marting's new AI Doctor — Dr Gupta 51:08 What's the FDA going to say? 53:26 Problems with GPT-4; hallucinations and sources 1:00:00 Mental health impact of being the most hated man in America 1:02:30 How rich are you? 1:08:00 Outro Daraprim is used to treat or prevent parasitic diseases, commonly in patients with HIV or AIDS. He defended the move by saying “If there was a company that was selling an Aston Martin at the price of a bicycle, and we buy that company and we ask to charge Toyota prices, I don't think that that should be a crime.” Unrelated to the Daraprim scandal, in 2017 he was charged with securities fraud and sentenced to seven years in prison and fined a total of over $70M dollars. Martin comes from humble beginnings, his parents are Albanian immigrants — but he quickly ascended the world and became a multimillionaire polymath. And despite having no formal training in Medical Sciences — he has a penchant for consuming medical literature from PubMed, and making novel insights. We talk about how Martin does this, his philosophy around drug pricing — and whether we should think about pricing drugs in the same way we price iPhones, we talk about whether blowing more money into pharma research & development actually leads to more exciting drugs, Martin's new AI doctor that he just launched and the mental health impact of being the world's most hated man. You can find me on Twitter @MustafaSultan and subscribe to my newsletter on www.musty.io

Episode 445: Shaan Puri (@ShaanVP) and Sam Parr (@TheSamParr) talk with Martin Shkreli (@marty_catboy), aka "the most hated man in America", about how he got started in pharma, his logic behind raising the price of Daraprim, why he spent time in prison, and what business he's starting now. Vote for MFM to win a Webby: mfmpod.com/webby Click here to sign up for our event in Austin, TX on Saturday April 29th: mfmpod.com/atx Want to see more MFM? Subscribe to the MFM YouTube channel here. Check Out Sam's Stuff: * Hampton * Ideation Bootcamp * Copy That Check Out Shaan's Stuff: * Power Writing Course * Daily Newsletter ----- Links: *Dr. Gupta AI *@martinshkreli15 (Instagram) * Do you love MFM and want to see Sam and Shaan's smiling faces? Subscribe to our Youtube channel. ------ Show Notes: (00:30) - Intro to Martin Shkreli (02:10) - When Martin worked with Jim Cramer (23:00) - How he turned $2M into $1B in pharma (35:40) - Why did you jack up the price of the drugs? (54:20) - What do you do with your money? (01:00:33) - The Fun Strikes Back Movement (01:08:30) - Introducing Martin's New Company: Dr. Gupta AI (01:33:50) - Who are your heroes? ------ Past guests on My First Million include Rob Dyrdek, Hasan Minhaj, Balaji Srinivasan, Jake Paul, Dr. Andrew Huberman, Gary Vee, Lance Armstrong, Sophia Amoruso, Ariel Helwani, Ramit Sethi, Stanley Druckenmiller, Peter Diamandis, Dharmesh Shah, Brian Halligan, Marc Lore, Jason Calacanis, Andrew Wilkinson, Julian Shapiro, Kat Cole, Codie Sanchez, Nader Al-Naji, Steph Smith, Trung Phan, Nick Huber, Anthony Pompliano, Ben Askren, Ramon Van Meer, Brianne Kimmel, Andrew Gazdecki, Scott Belsky, Moiz Ali, Dan Held, Elaine Zelby, Michael Saylor, Ryan Begelman, Jack Butcher, Reed Duchscher, Tai Lopez, Harley Finkelstein, Alexa von Tobel, Noah Kagan, Nick Bare, Greg Isenberg, James Altucher, Randy Hetrick and more. ----- Additional episodes you might enjoy: • #224 Rob Dyrdek - How Tracking Every Second of His Life Took Rob Drydek from 0 to $405M in Exits • #209 Gary Vaynerchuk - Why NFTS Are the Future • #178 Balaji Srinivasan - Balaji on How to Fix the Media, Cloud Cities & Crypto * #169 - How One Man Started 5, Billion Dollar Companies, Dan Gilbert's Empire, & Talking With Warren Buffett • ​​​​#218 - Why You Should Take a Think Week Like Bill Gates • Dave Portnoy vs The World, Extreme Body Monitoring, The Future of Apparel Retail, "How Much is Anthony Pompliano Worth?", and More • How Mr Beast Got 100M Views in Less Than 4 Days, The $25M Chrome Extension, and More

Martin Shkreli was once branded the most hated CEO in USA history. He got this title when he infamously increased the price of Daraprim from $13.50 to $750 per pill. Different Lawsuits soon came in, and he was eventually jailed for 7 years. But was Martin Shkreli as evil as the media portrays him to be? Why did he raise the drug prices? What is his side of the story? Martin Shkreli himself joined me on the Survival Skills Podcast where he talked about his side of the story, why he was jailed, what life was like in prison And his opinion on cryptocurrencies. Watch the video version of this episode on Youtube    Click Here

In September 2015, Martin Shkreli quickly became ‘the most hated man in America' after he raised the price of the life-saving drug, Daraprim, by more than 4,000% - almost overnight. Instead of apologising or hiding away, Shkreli decided to lean into his villain image, with even more media appearances and antagonising acts. In an interview with The Hustle magazine, Shkreli was quoted as saying: “People want a villain,” “If people derive some psychological benefit from that, then I don't want to deprive them of it. I'll be your villain.” Shkreli lied with regularity, harassed female journalists and even took on the Wu-Tang Clan. At his securities fraud trial almost 200 jurors were ‘excused' during jury selection because as one juror said: “The only thing I'd be impartial about is what prison this guy goes to.” In part two, Dr Julia Shaw and Sofie Hagen discuss the latest research on ‘hate'. Why do we hate? Whom do we hate? And can one love to be hated? They also talk about jury selection and whether it is ever possible to have a completely unbiased jury.CREDITS Presenters: Dr Julia Shaw and Sofie Hagen Producer: Simona Rata Music: Matt Chandler Editor: Anna Lacey #BadPeople_BBC Commissioning Assistant Producer: Adam Eland Commissioning Executive: Dylan Haskins Bad People is produced in partnership with The Open University and is a BBC Audio Science Production for BBC Sounds.

In September 2015, Martin Shkreli's name made headlines. He quickly became ‘the most hated man in America' after he raised the price of the life-saving drug, Daraprim, by more than 4,000% - almost overnight. He was vilified by the press and the public alike and was often referred to as ‘pharma bro', a representation of everything that was seemingly wrong with Big Pharma. Was Martin Shkreli unfairly singled out? How was any of it legal? And is ruthlessness in business justified?This is part one of two. On this episode of Bad People Dr Julia Shaw and Sofie Hagen discuss greed and whether it's inherently bad. This episode includes audio from the 2021 documentary ‘Pharma Bro' by Blumhouse Productions, directed by Brent Hodge. CREDITS Presenters: Dr Julia Shaw and Sofie Hagen Producer: Simona Rata Music: Matt Chandler Editor: Anna Lacey #BadPeople_BBC Commissioning Assistant Producer: Adam Eland Commissioning Executive: Dylan Haskins Bad People is produced in partnership with The Open University and is a BBC Audio Science Production for BBC Sounds.

Martin Shkreli IS THE FREAKING WORST! The 38-year-old financial entrepreneur and pharmaceutical tycoon from Brooklyn was dubbed "the most hated man in America"  in 2015 for price gouging the prescription drug Daraprim by 5500% overnight depriving AIDS patients, people with cancer, and pregnant people of the life-saving medication. That same year, Shkreli purchased the Wu-Tang Clan's single copy of "Once Upon a Time in Shaolin" for 2 million dollars, AND THEN TALKED TRASH ABOUT WU -TANG EVERY CHANCE HE GOT. Prepare to get fired up, Fam! HERE ARE OUR ADDED TOUR DATES!!--PATRICK IS HITTING THE ROAD WITH  MAGGIE, AND LANCE & TIM TO DO THE LIVE SHOW COVERING "THE DISAPPEARANCE OF MAURA MURRAY." Gillian will not be joining us BUT SHE LOVES YOU AND CAN'T WAIT TO SEE YOU AT OBSESSED FEST! Wednesday, August 3: Orlando, FL Thursday, August 4: West Palm Beach, FL Saturday, August 6: Atlanta, Georgia Friday, August 19: St. Paul, MN Saturday, August 20: Dallas, TX Sunday, August 21: Houston TX LOOKING FOR MORE TCO? On our Patreon feed, you'll find over 300 FULL BONUS episodes to BINGE RIGHT NOW! Including our episode-by-episode coverage of "LuLaRich" "John Wayne Gacy: Devil in Disguise" "Night Stalker" "The Jinx," "Making A Murderer," "The Staircase," "I'll Be Gone in the Dark," "A Wilderness of Error" "The Vow"  "Tiger King" "Don't F**K With Cats," "The Menendez Murders," "The Murder of Laci Peterson," "Casey Anthony: American Murder Mystery," "Serial," "Lorena," "The Disappearance of Madeleine McCann," "OJ: Made in America" and so many more! JOIN HERE! COME TO OBSESSED FEST!! It's the first-ever OBSESSED NETWORK FAMILY WEEKEND! It's going to be a weekend full of live shows--OWD Friday night, TCO Saturday night (and two non-Obsessed Network live shows as well!), meet & greets, KARAOKE!, meetups, panel chats AND. ONE. INSANE. DRAG. BRUNCH!!! It's all happening at the Hyatt Regency in Columbus, Ohio from September 30 - October 2nd. TICKETS ARE ALMOST GONE!! GET YOUR TICKET

Martin Shkreli, ‘the most hated man in America', purchased the one extant copy of the Wu-Tang Clan's concept album ‘Once Upon A Time In Shaolin' for $2 million on 3rd May, 2015.  In seeking to sell their record in an auction, the hip-hop collective had been inspired by the concept of wealthy patrons funding Renaissance artists - but hadn't counted on the winning bidder being the ‘pharma bro' notorious for raising the price of toxoplasmosis drug Daraprim by a factor of 56. In this episode, Arion, Rebecca and Olly consider whether Shkreli's ‘price gouging' antics made him an (in)appropriate buyer; ask whether it can really be true that the multimillionaire didn't even bother listening to his purchase; and explain what happened to the CD after Shkreli was imprisoned for fraud… Further Reading: • Everything I Know About the Wu-Tang Album from Hanging Out with Martin Shkreli (VICE, 2016): https://www.vice.com/en/article/3bjmq9/everything-i-know-about-the-wu-tang-clan-album-from-hanging-out-with-martin-shkreli • ‘Wu-Tang clap back, dissing Martin Shkreli on new track' (The Guardian, 2017): https://amp.theguardian.com/us-news/2017/sep/22/wu-tang-clan-martin-shkreli-track • ‘Martin Shkreli on Drug Price Hikes and Playing the World's Villain' (VICE, 2016): https://www.youtube.com/watch?v=2PCb9mnrU1g For bonus material and to support the show, visit Patreon.com/Retrospectors We'll be back tomorrow! Follow us wherever you get your podcasts: podfollow.com/Retrospectors The Retrospectors are Olly Mann, Rebecca Messina & Arion McNicoll, with Matt Hill. Theme Music: Pass The Peas. Announcer: Bob Ravelli. Graphic Design: Terry Saunders. Edit Producer: Alexa Weissman. Copyright: Rethink Audio / Olly Mann 2022. Hosted on Acast. See acast.com/privacy for more information. Learn more about your ad choices. Visit podcastchoices.com/adchoices

If ever there was a villain origin story...this is it. Pharma Bro is a profiling of the notorious Martin Shkreli, the pharmaceutical tycoon and resident weirdo from Brooklyn, New York. You may remember him from hits like raising the cost of Daraprim by 5000% or from buying the infamous Wu Tang Clan album for 2 million to use it as a coaster. What's even more baffling are the lengths the filmmaker went to get up close and personal with this myth of a man.

If ever there was a villain origin story...this is it. Pharma Bro is a profiling of the notorious Martin Shkreli, the pharmaceutical tycoon and resident weirdo from Brooklyn, New York. You may remember him from hits like raising the cost of Daraprim by 5000% or from buying the infamous Wu Tang Clan album for 2 million to use it as a coaster. What's even more baffling are the lengths the filmmaker went to get up close and personal with this myth of a man.

Welcome to The Nonlinear Library, where we use Text-to-Speech software to convert the best writing from the Rationalist and EA communities into audio. This is: Act of Charity , published by jessicata on the LessWrong. (Cross-posted from my blog) The stories and information posted here are artistic works of fiction and falsehood. Only a fool would take anything posted here as fact. Anonymous Act I. Carl walked through the downtown. He came across a charity stall. The charity worker at the stall called out, "Food for the Africans. Helps with local autonomy and environmental sustainability. Have a heart and help them out." Carl glanced at the stall's poster. Along with pictures of emaciated children, it displayed infographics about how global warming would cause problems for African communities' food production, and numbers about how easy it is to help out with money. But something caught Carl's eye. In the top left, in bold font, the poster read, "IT IS ALL AN ACT. ASK FOR DETAILS." Carl: "It's all an act, huh? What do you mean?" Worker: "All of it. This charity stall. The information on the poster. The charity itself. All the other charities like us. The whole Western idea of charity, really." Carl: "Care to clarify?" Worker: "Sure. This poster contains some correct information. But a lot of it is presented in a misleading fashion, and a lot of it is just lies. We designed the poster this way because it fits with people's idea is of a good charity they should give money to. It's a prop in the act." Carl: "Wait, the stuff about global warming and food production is a lie?" Worker: "No, that part is actually true. But in context we're presenting it as some kind of imminent crisis that requires an immediate infusion of resources, when really it's a very long-term problem that will require gradual adjustment of agricultural techniques, locations, and policies." Carl: "Okay, that doesn't actually sound like more of a lie than most charities tell." Worker: "Exactly! It's all an act." Carl: "So why don't you tell the truth anyway?" Worker: "Like I said before, we're trying to fit with people's idea of what a charity they should give money to looks like. More to the point, we want them to feel compelled to give us money. And they are compelled by some acts, but not by others. The idea of an immediate food crisis creates more moral and social pressure towards immediate action, than the idea that there will be long-term agricultural problems that require adjustments. Carl: "That sounds...kind of scammy?" Worker: "Yes, you're starting to get it! The act is about violence! It's all violence!" Carl: "Now hold on, that seems like a false equivalence. Even if they were scammed by you, they still gave you money of their own free will." Worker: "Most people, at some level, know we're lying to them. Their eyes glaze over 'IT IS ALL AN ACT' as if it were just a regulatory requirement to put this on charity posters. So why would they give money to a charity that lies to them? Why do you think?" Carl: "I'm not nearly as sure as you that they know this! Anyway, even if they know at some level it's a lie, that doesn't mean they consciously know, so to their conscious mind it seems like being completely heartless." Worker: "Exactly, it's emotional blackmail. I even say 'Have a heart and help them out'. So if they don't give us money, there's a really convenient story that says they're heartless, and a lot of them will even start thinking about themselves that way. Having that story told about them opens them up to violence." Carl: "How?" Worker: "Remember Martin Shkreli?" Carl: "Yeah, that asshole who jacked up the Daraprim prices." Worker: "Right. He ended up going to prison. Nominally, it was for securities fraud. But it's not actually clear that whatever security fraud he did was worse than what others in his industry were doing. Rather, it seems likely that he was especially targeted because he was a heartless asshole." Carl: "But he still brok...

Sam and Thomas discuss the Epstein/Maxwell child sex trafficking trial, the people killed in the Champlain Towers Collapse, Pharma Bro Martian Shkreli's Anti-Parasitic Drug Daraprim and much more… Broadcasting in the California Central Valley Here: Comcast Xfinity Ch. 93, AT&T U-Verse Ch. 99 Cablecast app on Roku or Apple TV https://cmac.tv/apps/ https://cmac.tv/series/weaponized-news/ Share and Follow and Subscribe to: Thomas Alpha Omega Energy "We Changed The World!" +855 818 55 800 (Also Whatsapp) aomegaenergy.com Twitter: https://twitter.com/AOECOINnews Telegram: AlphaOmegaEnergy Share and Follow and Subscribe to Weaponized News http://weaponizednews.com/ https://anchor.fm/weaponizednews https://www.brighteon.com/channels/weaponizednews https://odysee.com/@WeaponizedNews:6 https://www.bitchute.com/channel/t8y7ptaYWaFl/ https://gab.com/WeaponizedNews https://twitter.com/WeaponizedNews Help the Weaponized News Pay Some Bills Donate https://www.paypal.com/donate?token=SMJThaUrGts7xg3e2v_QRwXmPibJym12pzJPcjpi9xwKo1HAm0WlcJUal43SKOErssQYynjCc6t8DGoC Bitcoin 36fNy89D8vnmH2Ty14ceeoaoomHzGvsH8o Ethereum 0x5dAE62B94C83290dB599A4917003db95EeC365B6 XRP rw2ciyaNshpHe7bCHo4bRWq6pqqynnWKQg:::ucl:::714284265

PHARMA BRO chronicles the shooting star life and times of Martin Shkreli, the 38-year-old financial entrepreneur and pharmaceutical tycoon from Brooklyn, New York, was dubbed “the most hated man in America” by the media after he rose to infamy in 2015 for price gouging the prescription drug Daraprim by 5500% overnight depriving patients of the life-saving medication. Hodge presents a new in-depth look on the all-too familiar media tale in PHARMA BRO a concentrated year-long study of the man who defies traditional categorization. Through traveling to Shkrel, Albania to learn about his heritage and uncover his backstory; visiting hospitals and talking with Daraprim patients; watching countless hours of his live-stream; and uncovering the real story about the Wu-Tang album, Hodge is able to provide new and alternative insight from a variety of sources, who offer commentary on Shkreli and his story of promising financial savant turned pharma opportunist and the fortune he acquired at the detriment of others. Combining live streams, sit-down interviews, news footage, filmed scenes and actual encounters with Shkreli, Hodge presents a prismatic image of PHARMA BRO, the differing sides he consciously (and sometimes unconsciously) presented and a cinematic examination of the qualities that earned him his most hated status. The film features Wu-Tang Clan's Ghostface Killah, musical artist The Fridge, Journalist Christie Smythe, and Shkreli Defense Attorney Ben Brafman. Director Brent Hodge (A Brony Tale, I Am Chris Farley, Freaks and Geeks: The Documentary) joins us for a lively conversation on why he wanted to go behind the headlines to explore the how and why of the Shkreli's life as well as his personal commitment to being even-handed in telling the whole story of “the most hated man in America.” For news and updates go to: 1091pictures.com

Martin Shkreli became infamous as the smug “pharma bro” who raised the price of HIV drug Daraprim from $13.50 to $750.00 per tablet. But is he evil? Or is he the inevitable outcome of America's poorly regulated pharmaceutical industry? And what about that $2 million Wu-Tang Clan album he bought? Or the Bloomberg journalist who fell in love with him? This week, Evil Men takes a nice, juicy look at currently incarcerated cartoon villain Martin Shkreli. Enjoy! PLUS: Chris talks about getting retweeted by Flea, Michael reflects on “white boy summer” and James goes to a baseball game. Support Evil Men on Patreon for exclusive monthly bonus episodes and SPECIAL  MATERIAL. Follow Evil Men on Twitter and Instagram. And rate and review us wherever possible! Brought to you By: The Sonar Network

El derecho tiene un poco de arte y un poco de ciencia, los argumentos y las pruebas hacen o deshacen un caso. Navegamos en el libro "Copycat: La delgada línea de la Propiedad Intelectual (Un compendio de propiedad intelectual nº 8)" junto a su autor Ricardo Rodríguez, quien nos habla de la Propiedad Intelectual vista desde otras perspectivas y usando términos del mundo de los negocios y la mercadotecnia. 

Although there is little question as to the need for affordable, accessible, and high-quality pharmaceuticals, there is immense disagreement as to how best to achieve that end. What are the key issues facing pharmaceutical antitrust enforcement today? Michael Kades, Director of Markets and Competition Policy for the Washington Center for Equitable Growth, joins Christina Ma and John Roberti to discuss the current state of pay-for-delay, the FTC's Daraprim case, FTC restitution before SCOTUS, and biologics. Listen to this episode for a quick primer on things to pass and things to come in pharmaceutical antitrust enforcement. Related Links: https://equitablegrowth.org/competitive-edge-underestimating-the-cost-of-underenforcing-u-s-antitrust-laws/ https://equitablegrowth.org/congress-adopts-historic-prescription-drug-pricing-reform/ https://www.ftc.gov/system/files/documents/cases/2020.01.27_daraprim_complaint_final_redacted.pdf https://www.supremecourt.gov/DocketPDF/19/19-825/126165/20191219140044609_No.%2019-__%20PetitionForAWritOfCertiorari%20and%20Appendix%20FTC%20v.%20Credit%20Bureau%20Center.pdf Hosted by: Christina Ma, Associate, Wachtell Lipton Rosen & Katz and John Roberti, Partner, Allen & Overy

'After all, isn't sharing knowledge and discovery what science is really all about?' This program first aired September 23, 2018

'After all, isn't sharing knowledge and discovery what science is really all about?' This program first aired September 23, 2018

A Revolution in American Medicine is Long Overdue Richard Gale and Gary Null PhD July 6, 2020   The sweeping occurrence of CoV19 infections has contributed to a loss of jobs, careers, regular education for our children and has adversely impacted the health of otherwise healthy people. But for tens of millions of Americans who have lost their health insurance or have not been covered, the situation is more dire. One illness, one infectious disease, could push them over the edge into insolvency and bankruptcy. Now is the opportune time to change course, bail out all Americans and cease providing taxpayer gifts to Wall Street, the rich and powerful.  The fundamental problem with Obamacare, and the proposed combination of a Green New Deal and Medicare for All, is that both leave the unconscionable profit making in the system. The medical lobbies, insurance and hospital industries and Big Pharma assure that if you are hospitalized with CoV19 and don't have insurance, you will receive a bill for tens of thousands of dollars. There is no power in the US at this moment that would prevent these private industries from foregoing a $3.5 trillion windfall profit annually. Therefore the Democrats who claim they want universal healthcare want it only on the condition that the existing system is not upended. Yet that is exactly what is demanded at this moment. The onslaught of misinformation from the corporatist wings of both political parties and media biases against universal healthcare are obviously confusing the electorate. This confusion leaves citizens bewildered about how they will pay their bills unless a fundamental overhaul of medical insurance is undertaken. More important, what will happen if you are diagnosed with a serious illness and are not fully covered? What are your chances of joining the ranks of the 530,000 families that file bankruptcy annually for medical reasons?  According to a study published last year by the American Journal of Public Health, 66.5% of bankruptcies are medically-related.  In the past, it was rare for people to go bankrupt because they did not have accessible medical care. There was a time in the US when medicine carried a higher standard of ethics. The Hippocratic Oath was respected and no one was denied medical care because they could not afford it.  But that was in the past. Obama's Affordable Care Act, which Biden continues to believe is a successful piece of legislation, has done little to mitigate the increasing financial burden on individuals and families. In fact, quality of healthcare has steadily declined. Now with the CoV19 pandemic, we are witnessing patients forced to pay out of pocket enormous bills for diagnostic testing, ER visits, hospitalization and treatments. If you are returning to the country from overseas, you may be forced to pay for the time spent in quarantine even if you test negative for the virus.  And the pharmaceutical and insurance industries are already capitalizing on this disaster. The Democrat Party's full throttle assault to undermine the legitimacy of Bernie Sanders' campaign was orchestrated by the insurance and medical industrial complex, which has influenced unbridled bias across the media waves. The goal is to effectively sustain Obama's failed healthcare efforts. After listening to dozens of commentators on CNN, MSNBC, Fox, and the pseudo-health journalists at the New York Times, and Washington Post, the false impression was created to perceive Bernie as only offering free stuff to everyone and at enormous cost to taxpayers.  No one truly knows how much a national universal program would cost. Forecasts for a 10-year period range roughly between $13 trillion and $48 trillion. One thing is certain. The math is simple. It would be extremely expensive and for it to succeed dramatic infrastructural changes would need to be made throughout the entire healthcare system and how medicine is conventionally practiced.  That conversation is long overdue. However, perhaps this is the wrong argument because it is based upon the Democratic Party's deep seated cognitive dissonance to protect the vested interests of Wall Street's financial community, Biden's allegiance to the credit lending industry, the military industrial complex, and the pharmaceutical and agro-chemical industries. In effect, the entirety of corporate America and the deep state, its lobbyists and oligarchic billionaires, and their sounding board in the mainstream media, are on one side of the scale while the urgent humanitarian medical needs of average citizens are on the other.  All that weighs on the side of Medicare for All are the educated adults, unionists, working people, and those who understand climate change and the need for a comprehensive and equitable healthcare system. This still remains to be a revolution that must take place across the nation. So, how does such a revolution get launched? First, Medicare for All is doable and affordable. In fact, it can potentially save $1.7 trillion a year by removing from the equation unnecessary and unconscionable profit to private insurance providers, the drug makers and the large mega-hospital networks.  There is no reason for having so many levels of bureaucracy between direct medical care and the patient. Every industry directly involved in providing treatment and care would continue to profit. But it would be a reasonable profit. Instead we have a medical lobby that is excessively greedy and eager to take advantage of loopholes in order to milk the system for whatever it is worth. But we can only have a viable Medicare for All after we seriously look at what it costs to treat a patient and make efforts to reduce the exorbitant waste that has been programmed into our current system. How is it that a hospital can charge $787 for an adult and $393 for a child for a one dollar bag of intravenous saline solution, plus an additional $127 to administer it? Americans spend more on prescription medications than any other developed nation, as drug prices can soar ten times the rate of inflation.  Daraprim, for example, which is prescribed to fight one of the world's most common parasitical infections that causes toxoplasmosis, can cost $45,000 per month, or $750 for a single pill that costs $13.50 to manufacture. When we consider the costs for treating CoV19, the figures get even more outrageous. An average Medicare payment for a common respiratory infection is about $13,300, and over $40,000 for an infection requiring a ventilator. That was in 2017, and the average costs have increased 20 percent or more in less than three years. Average out of pocket costs for being hospitalized for pneumonia is $1,300 and much higher for those covered by small business insurance. Cases of uninsured people being treated for Cov19 have received medical bills upwards to $35,000 and conservatively there are 28 million uninsured citizens in the US at this moment and rising as unemployment increases.  Consequently only 1 in 7 Americans polled would not seek CoV treatment because of the cost. Based upon earlier figures between 2012-2015, about $2.6 trillion can be saved by removing bureaucratic waste and profiteering. This includes $275 billion on private insurance paperwork, $55.6 billion on liability insurance, $471 billion for insurance billing, $140 billion for medical fraud (2016), $210 billion for unnecessary medical testing, and $190 billion for wasteful administrative services.  Back in 2016, the British Medical Journal reported that medical error is the third leading cause of death in the US.  As a result over $1 trillion is spent on avoidable medical errors.  Universal healthcare will not break the economy. What is breaking the economy is our current broken medical system.  Universal, quality care is easily within reach but only after the health of the population is given preference over the healthcare system's vulture capitalists. Then Americans will no longer have to worry about bankruptcy, which further contributes to the stresses associated with ill health, because they cannot afford the treatments or medications without putting themselves and their family into perpetual debt. Second, providing universal healthcare does not guarantee that patients will receive quality care. If we are truly honest with ourselves and ask whether the US has the best medical care available, the answer should be a resounding no.  American emergency medicine is exemplary as is specialized surgery. However, chronic care for treating heart disease, cancer, diabetes, pain management and neurological and mental health conditions has been a dismal failure. More physicians need to be brought into the system without the anxiety of paying off enormous school debt and being forced to work to exhaustion.  We would be wise to make medical education free in return for young doctors committing themselves to charging reasonable fees if they wish to remain within the system. If a doctor prefers to gouge patients, that is their right to do so outside of the national system. Finally, the US lags far behind in a implementing a national preventative program. Very little has been done to prevent diseases shown to be directly related to life-style, diet and toxic conditions in our environment.  A viable prevention program would begin by supporting and mandating holistic health programs in our schools beginning with grade school. Why does offering school courses in "How to be Healthy" seem absurd when it has been shown repeatedly in the scientific peer-review literature and efforts in other advanced nations to avoid preventable illnesses and further reduce medical costs? But in order to launch a comprehensive preventative  program at a national scale, only respected educated health consumers should be in charge. Entities representing private corporate interests should be prohibited since they are responsible for the medical disasters that now demand for universal healthcare.  If Obamacare and the current corporate medical establishment were truly effective, there would be no discussion about Medicare for All. Hence this program would save nearly $2 trillion a year and help prevent tens of millions of diseases. The nation would be much healthier if comprehensive measures were taken to prevent disease in the first place. During the past three years we have sent on multiple occasions suggestions for implementing a Medicare for All to the Sanders' campaign and leading Democrats in Congress. But not a single person has responded. What does that tell us about the sincerity and commitment of those who profess universal healthcare but get their funding and marching orders from the drug industry?   Richard Gale is the Executive Producer of the Progressive Radio Network and a former Senior Research Analyst in the biotechnology and genomic industries.   Dr. Gary Null is the host of the nation's longest running public radio program on alternative and nutritional health and a multi-award-winning documentary film director, including The War on Health, Poverty Inc and Plant Codes.

By his early 30s, Martin Shkreli had held a variety of impressive roles; he was the co-founder of multiple successful hedge funds, CEO of biotechnology firm Retrophin; and founder and CEO of Turing Pharmaceuticals. So, how did young Martin Shkreli, with no formal training in chemistry and a Bachelor's Degree in business administration, become a pharmaceutical CEO and have an estimated worth by Fortune magazine in 2016 of $45 million? And how did Martin Shkreli only a few years later become a convicted felon worth practically nothing; referred to by the media as "Pharma Bro" and "the most hated man in America"? And whatever happened to that unreleased Wu Tang Clan Album Martin Shkreli bought for $2 million? Find out today on the Controversial Figures Podcast.Connect with us on Twitter: https://twitter.com/FiguresPodcastEpisode Sources:CNBC https://www.cnbc.com/2019/08/07/retrophin-paid-martin-shkreli-to-settle-all-legal-claims.htmlNetFlix Dirty Money, Drug Short episodeVanity Fair https://www.vanityfair.com/news/2015/12/martin-shkreli-pharmaceuticals-ceo-interviewWikipediaMartin Shkreli https://en.wikipedia.org/wiki/Martin_ShkreliNaked Short Sell https://en.wikipedia.org/wiki/Naked_short_sellingOnce Upon a Time in Shaolin https://en.wikipedia.org/wiki/Once_Upon_a_Time_in_ShaolinXconomy https://xconomy.com/san-diego/2019/08/22/retrophin-sinks-as-drug-pharma-bro-martin-shkreli-co-invented-fails/ Music: The 6 is Silent by SkyjellyBuzzsprout - Let's get your podcast launched! Start for FREEDisclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you.Support the show (https://www.patreon.com/controversialfigurespod)

Today we talk about the ban on certain electrical stimulation devices, the latest COVID-19 news, a first generic of Daraprim, a New Drug Application for a potential microneedle migraine treatment patch, and a first over-the-counter combination of ibuprofen and acetaminophen: Advil Dual Action.

HAPPY NEW YEAR A Decade Marked By Outrage Over Drug Prices Martin Shkreli, the former CEO of Turing Pharmaceuticals, who was called before Cummings' committee in2016. After hiking the price of an old drug for parasitic infections to $750 a pill from $13.50, Shkreli became the poster boy for pharmaceutical greed that helped define the past decade. Meanwhile, nearly 1 in 4 Americans has trouble affording prescription drugs, according to a Kaiser Family Foundation poll. Of relevance, perhaps to our NA members, Daraprim: An old drug gets a huge new price For decades, Daraprim has been the go-to medicine for treating toxoplasmosis, a parasitic infection especially dangerous for people with compromised immune systems, such as people living with HIV and patients who've undergone organ transplants. The drug was approved by the Food and Drug Administration in 1953, and its patents expired long ago. But there wasn't a generic version available, and there was only one supplier in the United States. Even so, Daraprim cost just $13.50 a pill in early 2015. Then Turing Pharmaceuticals bought the rights to the drug and raised its list price more than 5,000% overnight. Another company called Valeant did the same year when it bought two old heart drugs — Isuprel and Nitropress — that had little competition. Despite public outcry, Daraprim's price hasn't budged. Today, many health insurance companies won't pay for the drug, and it's too expensive for many hospitals to keep in stock, says Armstrong. As a result, she says, doctors have been forced to turn to cheaper alternatives that have more side effects and less proof that they work. Then there is EpiPen, used to counteract allergic reactions. By the time the EpiPen's list price reached $300 per auto-injector in 2016, its manufacturer, Mylan, had made more than a dozen price hikes in just six years. People clamored for a cheaper generic of the product, which injects a dose of epinephrine to counteract allergic reactions. Mylan had a virtual monopoly on it. In the spring of 2016, the FDA had rejected two applications from other firms that wanted to make generic versions. State and federal lawmakers took notice. For years, they had been passing laws that pushed for schools and other public places to have EpiPens on hand. Mylan started offering its own generic at half the price in December 2016 and left the price of its brand-name product where it was. Mylan's new version is called an authorized generic. These are usually introduced to undercut competition from other companies' generics — and eat into some of the competitors' profits. Next consider Sovaldi: a first-of-its-kind hepatitis C drug, priced at $1,000 per pill. To rid a patient of the hepatitis C virus would cost $84,000 per person. State health systems struggled to pay for the treatment, and health insurers denied the drug to all but the sickest patients. An investigation led by Iowa Republican Sen. Chuck Grassley and Oregon Democratic Sen. Ron Wyden found that state Medicaid programs spent more than $1 billion on the drug in 2014, but less than 2.4% of Medicaid patients with hepatitis C got Sovaldi. Now, there are a few other brand-name hepatitis C cures on the market, creating some competition. Finally: Insulin After insulin was discovered nearly 100 years ago, the rights to it were transferred to the University of Toronto for $1 so that insulin could be made widely available at a low cost. But insulin prices have continued to creep upward at a rate that's higher than inflation. As a result, some patients have rationed their medicine, skipping doses or cutting them in half. In 2017, a group of patients sued the three major insulin-makers — Sanofi, Eli Lilly and Novo Nordisk — when they noticed that the companies were increasing their prices in lockstep. When Congress and the media took notice, the price hikes mostly stopped, but prices didn't drop. In December, the House passed a bill to lower prescription drug prices.

HAPPY NEW YEAR A Decade Marked By Outrage Over Drug Prices Martin Shkreli, the former CEO of Turing Pharmaceuticals, who was called before Cummings' committee in2016. After hiking the price of an old drug for parasitic infections to $750 a pill from $13.50, Shkreli became the poster boy for pharmaceutical greed that helped define the past decade. Meanwhile, nearly 1 in 4 Americans has trouble affording prescription drugs, according to a Kaiser Family Foundation poll. Of relevance, perhaps to our NA members, Daraprim: An old drug gets a huge new price For decades, Daraprim has been the go-to medicine for treating toxoplasmosis, a parasitic infection especially dangerous for people with compromised immune systems, such as people living with HIV and patients who've undergone organ transplants. The drug was approved by the Food and Drug Administration in 1953, and its patents expired long ago. But there wasn't a generic version available, and there was only one supplier in the United States. Even so, Daraprim cost just $13.50 a pill in early 2015. Then Turing Pharmaceuticals bought the rights to the drug and raised its list price more than 5,000% overnight. Another company called Valeant did the same year when it bought two old heart drugs — Isuprel and Nitropress — that had little competition. Despite public outcry, Daraprim's price hasn't budged. Today, many health insurance companies won't pay for the drug, and it's too expensive for many hospitals to keep in stock, says Armstrong. As a result, she says, doctors have been forced to turn to cheaper alternatives that have more side effects and less proof that they work. Then there is EpiPen, used to counteract allergic reactions. By the time the EpiPen's list price reached $300 per auto-injector in 2016, its manufacturer, Mylan, had made more than a dozen price hikes in just six years. People clamored for a cheaper generic of the product, which injects a dose of epinephrine to counteract allergic reactions. Mylan had a virtual monopoly on it. In the spring of 2016, the FDA had rejected two applications from other firms that wanted to make generic versions. State and federal lawmakers took notice. For years, they had been passing laws that pushed for schools and other public places to have EpiPens on hand. Mylan started offering its own generic at half the price in December 2016 and left the price of its brand-name product where it was. Mylan's new version is called an authorized generic. These are usually introduced to undercut competition from other companies' generics — and eat into some of the competitors' profits. Next consider Sovaldi: a first-of-its-kind hepatitis C drug, priced at $1,000 per pill. To rid a patient of the hepatitis C virus would cost $84,000 per person. State health systems struggled to pay for the treatment, and health insurers denied the drug to all but the sickest patients. An investigation led by Iowa Republican Sen. Chuck Grassley and Oregon Democratic Sen. Ron Wyden found that state Medicaid programs spent more than $1 billion on the drug in 2014, but less than 2.4% of Medicaid patients with hepatitis C got Sovaldi. Now, there are a few other brand-name hepatitis C cures on the market, creating some competition. Finally: Insulin After insulin was discovered nearly 100 years ago, the rights to it were transferred to the University of Toronto for $1 so that insulin could be made widely available at a low cost. But insulin prices have continued to creep upward at a rate that's higher than inflation. As a result, some patients have rationed their medicine, skipping doses or cutting them in half. In 2017, a group of patients sued the three major insulin-makers — Sanofi, Eli Lilly and Novo Nordisk — when they noticed that the companies were increasing their prices in lockstep. When Congress and the media took notice, the price hikes mostly stopped, but prices didn't drop. In December, the House passed a bill to lower prescription drug prices.

WTF Moments: The pharmaceutical and health product industry is by far the biggest spender in terms of lobbying American politicians. Collectively they have spent more than $3.1 billion dollars attempting to influence our elected lawmakers- I wonder what their expense reports look like...9 out of 10 pharmaceutical companies spend more than twice as much on marketing and advertising than research and development. In extreme cases, pharmaceutical companies have raised their prices over 1,000% - In 2015, Valeant Pharmaceuticals raised the price of their drug Daraprim over 5,000%.Halitosis was invented by Listerine. The son of the owner came up with the plan in order to increase direct sales to consumers- they shamed you so hard. Have y’all seen these Listerine ads? They are amazing. According to TIME Magazine- The price of 60 prescription drugs doubled during a recent 12-month span, and prices for 20 of these medications at least quadrupled.Prescription drug spending hit $425 billion in the U.S. last year, before discounting, and the total is expected to reach $640 billion by 2020, according to data from IMS Health Incorporated. Check out our website!Contact us!Support the show (https://www.patreon.com/join/cocktailsandconspiracies?)

In this installment of the Future Grind podcast, host Ryan O'Shea is joined by Michael Laufer. Michael is a mathematician and university professor who has turned his attention to do-it-yourself pharmaceuticals, creating and disseminating open-source plans for low-cost alternatives to expensive medical treatment. He is the chief spokesperson for the Four Thieves Vinegar Collective, and he received a lot of media attention in 2016 after creating a $30 DIY alternative to the EpiPen, which is 10x cheaper than they could be purchased for. His work has been featured by Scientific American, IEEE, Vice, CNN, and more. We discuss the future of healthcare, information as power, and subversion. A word of warning - in this episode, we discuss the production and potential use of home-made pharmaceuticals. Ingesting any of these compounds should be considered extremely dangerous, and things can go wrong. I advise consulting with a trained medical doctor and seeking expert opinions before taking your healthcare into your own hands. Show Notes: https://futuregrind.org Follow along - Twitter - https://twitter.com/Ryan0Shea Instagram - https://www.instagram.com/ryan_0shea/ Facebook - https://www.facebook.com/RyanOSheaOfficial/

Martin Shkreli is often described as the "most hated man in America” for raising the price of a lifesaving drug by 5,000%, earning him the nickname "Pharma bro." Shkreli said his pharmaceutical company raised the price of Daraprim from $13.50 a pill to $750 in order to spend that money on research for an alternative drug, a claim which medical experts widely derided. Now, Shkreli is back in the news and on trial for securities fraud, and while others in his situation might sit quietly and await the verdict, that's not what Shkreli is doing. He can't help himself from making even more attention grabbing headlines.  This week on Money Talking, Host Charlie Herman talks with Renae Merle, a Wall Street and white collar crime reporter for the Washington Post, and Sheelah Kolhatkar, staff writer for the The New Yorker and author of Black Edge: Inside Information, Dirty Money, and the Quest to Bring Down the Most Wanted Man on Wall Street about Shkreli’s case and what it could say about the prosecution of white collar crimes.

Hello, and welcome to The Rob Burgess Show. I am, of course, your host, Rob Burgess. On this, our 13th episode, our guest is Martin Shkreli. Shkreli, a former hedge fund manager and Turing Pharmaceuticals CEO, became internationally infamous in October 2015 when he purchased Daraprim, a drug used to treat toxoplasmosis. There is a good chance you already host toxoplasmosis, especially if you have a cat, but you may never know it. Only children, pregnant mothers and those with weakened immune systems are at risk for developing symptoms. But for those who do, the symptoms can be severe, even fatal. The medication used to treat patients, pyrimethamine, has been available since 1953. Shkreli inspired indignation when he upped the price of the drug by over 5,000 percent from $13.50 per pill to $750. Then, in December 2015, he was arrested by the FBI for securities fraud. He is currently out on bail. On Feb. 4, Shkreli testified before the Committee on Oversight and Government Reform of the U.S. House of Representatives. You'll first hear Shkreli and Republican Utah Rep. Jason Chaffetz and then Republican South Carolina Rep. Trey Gowdy. The album you heard mentioned in another story entirely. Starting in 2008, rap group the Wu-Tang Clan spent five years recording an album only one person, one who couldn't legally profit from until 2103. In May 2015, Shkreli was the winner of an auction for the album, paying $2 million. Here's Wu-Tang Clan leader The RZA being interviewed by Jan. 6, by Bloomberg, who broke the story in December 2015. Later in January, Wu-Tang Clan member Ghostface Killah was asked about Shkreli by TMZ. He responded by calling him a shithead. A few days later, TMZ published a video response from Shkreli, who, stemless wine glass in hand, had three masked men placed behind him. During his Feb. 3 appearance on Power 105.1's “The Breakfast Club,” Shkreli added fuel to the fire. A few days later, Ghostface Killah issued a video response that doubled as a promotion for his CBD oil, Wu Goo. You get the idea. So, here's how I happened to speak with Shkreli. On May 27, Shkreli tweeted the following: “I haven't been called by the Trump camp. I support him vs. Hillary. He should find a VP candidate who is seasoned in politics, an ugly game.” The same day, Colin Daileda of Mashable published an article titled: “America's most hated man endorses its most hated presidential candidate.” On May 28, Shkreli published his phone number, 646-217-2783, on Twitter and asked people who hate him to call him to prove Daileda were wrong. From there, Shkreli and I tweeted back and forth and I dialed his number on a phone without a redial button I knew of for more than 30 minutes. Finally, I got through. I want to thank Josh Sigler and Brandon Chapman of the Sounding Off w/Chap & Sig podcast for the shout outs on their last two episodes. If you're into unfiltered sports talk, I highly suggest checking them out on on Facebook, Twitter, SoundCloud and iTunes. You can help The Rob Burgess Show reach a wider audience by rating, reviewing and subscribing to the podcast on iTunes at tinyurl.com/therobburgessshow. You can also find The Rob Burgess Show on: Stitcher at www.stitcher.com/podcast/the-rob-burgess-show. Google Play Music at tinyurl.com/therobburgessshowgoogleplay. TuneIn at tinyurl.com/therobburgessshowtunein. YouTube at tinyurl.com/therobburgessshowyoutube. You can also subscribe directly to the RSS feed at tinyurl.com/therobburgessshowrss. If you're an Android user visit subscribeonandroid.com/tinyurl.com/therobburgessshowrss You can find more about me by visiting my website, www.thisburgess.com. Follow on Twitter at www.twitter.com/robburgessshow. Like the page on Facebook at facebook.com/therobburgessshow. Follow on SoundCloud at soundcloud.com/the-rob-burgess-show. The email for the show is: therobburgessshow@gmail.com.

Former Turing Pharmaceuticals CEO Martin Schkreli was under the microscope of the govenrment recently due to his poor business practices. But are price controls the answer in the already heavily regulated Pharmaceuticals market? Sincere we are anarchists, you no doubt know our opinion on the matter.Martin Shkreli pleads the Fifth, then tweets about 'imbeciles' in CongressCostly Turing drug gets competitionPharmaceutical offers $1 option to Turing’s $750 AIDS drugDaraprimPharmaceuticals: Economics and RegulationPrice ControlsInterested in learning more about economics, logic, and history? Then sign up for Tom Woods Liberty Classroom.Interested in Bitcoin as an alternative to US Dollars? Use our Coinbase link!If you sign up with our coinbase link and purchase $100 in bitcoin, you will recieve an extra $10 from coinbase.The "Shift" Bitcoin debit card is through coinbase as well.Support the show by entering Amazon through our link HERE!Support the show with Bitcoin HERE!Use this address to add the Logical Anarchy Today show to your podcatcher or subscribe on iTunes!http://shoutengine.com/LogicalAnarchyToday.xml 

In the eighth installment of the OFID podcast, Editor Paul Sax, MD, delves into the headline-making pyrimethamine (Daraprim) saga where Turing Pharmaceuticals increased the price of the recently-acquired toxoplasmosis drug from $13 to $750 a pill. Aaron Kesselheim, MD, JD, MPH, and Joel Gallant, MD, MPH, join the discussion to shed light on what is unique about the generic drug market in the U.S. that makes these dramatic price increases possible and if there will be any resolution.

LHC tests Rainbow Gravity, Daraprim for a dollar by Ian Woolf, Bright Spark Elizabeth Hine describes how to see genes repaired for Fresh Science sparkler sessions, John August explains the Entropy and the Egg, part 2. Production checked by Charles Willock, Produced and hosted by Ian Woolf Support Diffusion by making a contribution

Topics Discussed: Mobile Podcasting from a Howard Johnson, Boise Idaho, Eating on the Road, Clubbing in Boise, Dave and Buster's Hustle, Flat Land Pressure Systems, Millennial Skill-based Gambling, Let's Do Some Drugs, Snitching Hard, Overstepping Your Bluff, Cheddar Addiction, Martin Shkreli, An Answer to Daraprim, Imprimis Pharmaceuticals, Capitalism Strikes Back, Hojo Experience, Friends and George Lopez, Motel Requirements, You Will Be Killed in a Motel, Summer Salmon Soup and Sushi Season, Idaho Laws, Having Sex in a Car, and Awesome Neighbors.   

// Video (Download): // Audio (Download): The post MePod No. 2 // 27 September 2015 // Daraprim and Shkreli appeared first on The Moral Economy.

There is a sinister smell in the air. Corrupt automakers, corrupt politicians, corrupt businesses, and corrupt religions. Choose your poison. 

So theres a guy named Martin Shkreli and he owns a company named Turing Pharmaceuticals. They have a drug called Daraprim used for HIV and he proudly announced this week that he raised the price from $13 a pill to $750 a pill like it was a great thing to do!  Well this pill has a serious group of users that have HIV and the world went into a tizzy cause Martin is proving why being a conservative greedy CEO of company is not cool.  Mark and Bobby discuss this.Then Mark and Producer Bobby go down a unique path as Mark talks about how we are just not happy with the Status quo anymore, yet we don't come up with anything more ingenius than the status quo.  They discuss how Lays potato chips are constantly trying to change the game with new weird flavors and there is nothing wrong with normal old Sour cream and Onion, Cheddar, BBQ and regular potato chips. Where do you stand?  Do you like the 900 varieties or were you fine and life worked well with the orignal 5-7 that already existed.  See where this goes on this episode of the Q. 

The price of Daraprim, a pharmaceutical drug for people with weak immune systems, recently went from $18 to over $750 per pill.

Are we tired of our Government crying wolf so they can keep us under control?

Hillary Clinton, the Democratic front runner in the race for the White House, pledged this week to crack down on the growing cost of prescription drugs and out of pocket medical expenses in the United States after Turing Pharmaceuticals announced that it was hiking the price of the drug Daraprim from $13.50 to $750 a pill. Aimee Keane asks David Crow about the sharp falls in biotech stocks that followed and whether plans such as Mrs Clinton's will end price-gouging. Music: "Starday" by Podington Bear. See acast.com/privacy for privacy and opt-out information.